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A B S T R A C T   
MicroRNAs (miRNAs) are noncoding RNA molecules that play a significant role in atherosclerosis pathogenesis 
through post-transcriptional regulation. In the present work, a bioinformatic analysis using TargetScan and 
miRdB databases was performed to identify the miRNAs targeting three genes involved in foam cell athero-
sclerosis (CD36, Vav3, and SOCS1). A total number of three hundred and sixty-seven miRNAs were recognized 
and only miR-155–5p was selected for further evaluation based on Venn analysis. Another objective of this study 
was to evaluate the biological process and regulatory network of miR-155–5p associated with foam cell 
atherosclerosis using DIANA, DAVID, Cytoscape, and STRING tools. Additionally, the comprehensive literature 
review was performed to prove the miR-155–5p function in foam cell atherosclerosis. miR-155–5p might be 
related with ox-LDL uptake and endocytosis in macrophage cell by targeting CD36 and Vav3 genes which was 
showed from the KEGG pathways hsa04979, hsa04666, hsa04145 H, hsa04810, and GO:0099632, GO:0060100, 
GO:0010743, GO:001745. Furthermore, miR-155–5p was also predicted to increase the cholesterol efflux from 
macrophage by inhibit SOCS1 expression based on KEGG pathway hsa04120. Eleven original studies were 
included in the review and strongly suggest the role of miR-155–5p in foam cell atherosclerosis inhibition.   
1. Introduction 
Atherosclerosis is the etiology of coronary heart, cerebrovascular, 
and peripheral arterial diseases [1–4]. The foam cell, a lipid-loaded 
macrophage, determines early phase of atherosclerosis, induces a 
chronic inflammation state, and drives atherogenesis into an advanced 
phase. The continuous uptake of oxidized LDL (ox-LDL) by scavenger 
receptors and the decrease of cholesterol efflux by macrophages are two 
factors that contribute to foam cell formation [5,6]. 
Remarkable studies demonstrated that Cluster Differentiation 36 
(CD36) accounts for a large proportion of foam cell formation by pro-
moting the 50% uptake of ox-LDL. This receptor has two transmembrane 
domains located near the N and C termini, leaving only short cyto-
plasmic tails at each end. Despite having small intracellular domains, the 
involvement of CD36 through its related cognate ligand triggers a 
reaction that leads to the internalization of the resulting complex 
[7–12]. 
The precise mechanism of ox-LDL internalization after binding to 
CD36 is mediated by Vav kinase, which primarily act as guanine 
nucleotide exchange factors (GEF) for the Rho/Rac/Cdc42 family of 
small GTPases. A previous study reported that this protein is upregu-
lated in the Src family kinase manner by activating the Fyn, Lyn, and 
subsequently Phospholipase C-γ1 (PLCγ1) expression. Furthermore, 
dynamin-2 is activated due to an increase of calcium influx. Hence, the 
endocytic vesicle size increase, membrane fission accelerates, and the 
ox-LDL endocytosis will increase. There are three structurally and 
functionally related members of the Vav kinase family. The Vav1 is 
expressed exclusively in hematopoietic cells, whereas Vav2 and Vav3 
are found ubiquitously in many cells [13–15]. Moreover, cholesterol 
accumulation in macrophages stimulates not only ABCA1-PPARγ 
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Table 1 
Profile of miRNAs targeting CD36, Vav3, and SOCS1.  
CD36 Vav3 SOCS1 
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dependent expression but also the reticulum-endoplasmic stress and 
inflammation process [16]. The Suppressor of Cytokine Signaling 1 
(SOCS1), an inflammatory transcription factor, play as an E3 ligase that 
degrade ATP-binding cassette transporter 1 (ABCA1), which is the main 
receptor for the efflux of cholesterol [17–19]. 
Complex genomic interaction in macrophages regulate foam cell 
formation in a positive or negative manner and act in several stages 
either transcriptionally, post-transcriptionally, or post-translationally. 
The microRNAs (miRNAs) are small non-coding transcript RNA with a 
length of 21–25 nucleotides and functions in post-transcriptional 
Fig. 1. The Venn analysis of miRNAs targeting 3′UTR of CD36, VAV3, and SOCS1 genes. Different shape and color represented the list of miRNAs targeting each 
gene. There was one miRNA shared by three genes which showed by shape overlaps. 
Table 2 
Profile of miR-155–5p seed sequences binding with 3′UTR target genes.  
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regulation of gene expression by translational repressor or by promoting 
the degradation of mRNA. Many miRNAs identified in human diseases 
include atherosclerosis-based disease. Nevertheless, there are lack of 
studies has proven the role of miRNAs in foam cell formation. Therefore, 
exploring specific miRNAs targeting the important molecule as the key 
player of atherogenesis has a potential role for the invention of new 
atherosclerosis’ therapeutic agents [20]. 
The aim of this study was to identify the miRNAs targeting 
3′Untranslated Region (UTR) of CD36, Vav3, and SOCS1 using open 
database tools. Furthermore, the evaluation of mature sequence, phys-
iological binding, and also conserved sites among different species were 
also presented. The other goal of this study was to investigate the bio-
logical process or molecular function of selected miRNA and its target 
genes which might be related to foam cell atherosclerosis. Additionally, 
the current literatures regarding the underlying function of miR-155–5p 
in foam cell formation were reviewed. 
2. Results 
2.1. Identification of miRNAs targeting CD36, Vav3, and SOCS1 
CD36, VAV3, and SOCS1 are proatherogenic proteins due to their 
action in macrophage cell. Therefore, identifying molecules that 
degrade these mRNAs is one important strategy to reduce the foam cell 
formation. An analysis using TargetScan 7.2 (http://www.targetscan. 
org/) showed that one hundred and thirty-five, one hundred and 
thirty-eight, and twenty-two miRNAs targeting 3′UTR of CD36, Vav3, 
and SOCS1, respectively (21). Based on miRdB analysis (http://mirdb. 
org/), forty-two, nine, and twenty-one miRNAs targeting 3′UTR of 
CD36, Vav3, and SOCS1, respectively (Table 1) [22,23]. Interestingly, 
Venn diagram analysis (http://jvenn.toulouse.inra.fr/app/example. 
html) demonstrated only one miRNA targeting three genes simulta-
neously (Fig. 1) [24]. 
2.2. Profile of common predicted miRNA 
From the previous step, miR-155–5p was selected for further anal-
ysis. The gene transcribed miR-155–5p was MIR155 (NCBI Gene ID 
406947) and located in chr21:25573980–25574044 (+). miR-155–5p 
mature sequences was 5′-UUAAUGCUAAUCGUGAUAGGGGUU-3’ 
(length = 24). Understanding the interaction between miR-155–5p seed 
sequences with 3′UTR of CD36, Vav3, and SOCS1 was crucial to make a 
prediction of miRNA stability and function. The interaction of this 
miRNA with 3′UTR of the genes were predicted by bioinformatic anal-
ysis in TargetScan 7.2 presented with context ++ score, conserved 
branch lengths, and PCT value (Table 2). From the data, it was 
concluded that seed sequences of miR-155–5p was UCGUAAU. 
The conservation analysis may provide evidence that a predicted 
miRNA target is functional and indicates that the sequences have been 
maintained by natural selection. The conserved sequences sites among 
eighteen species were depicted in Fig. 2. There was one conserved site 
for miR-155–5p interaction with Vav3 and SOCS1, four poorly 
conserved site for CD36, and one poorly conserved site for Vav3 among 
vertebrates. 
Fig. 2. The conserved sites for miR-155–5p binding in 3′UTR of CD36, Vav3, and SOCS1 in different species. The yellow color indicated the similar 3′UTR sequences 
among species. 
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2.3. Functional analysis of miR-155–5p and target genes 
The relatedness of miR-155–5p with CD36, Vav3, and SOCS1 in 
cellular network was investigated by Cytoscape 3.8.3, followed by 
determination pathway enrichment analysis with DIANA TOOLS - 
miRPath v.3 (http://snf-515788.vm.okeanos.grnet.gr/), Database for 
Annotation, Visualization and Integrated Discovery (DAVID) v6.8 
(https://david.ncifcrf.gov/), and STRING 11.0 (https://string-db.org/) 
[25–27]. From Fig. 3 it could be seen that Vav3 and SOCS1 involved in 
miR-155–5p networking, but not with CD36. It might be caused by the 
poorly conserved interaction between miR-155–5p and CD36. The 
below part of Fig. 3 showed that there was strong interaction between 
CD36, Fyn, Lyn, and Vav3. This finding supported the previous studies 
that reported the role of these proteins in ox-LDL endocytosis [14,15]. 
The activation of PPAR-γ cholesterol derivatives induce ABCA1 
expression [28,29]. However, the accumulation of this lipid activates 
the SOCS1 which act with Cullin and NEDD4 to degrade ABCA1 so the 
cholesterol efflux will be suppressed [30]. The role of miR-155–5p in 
this pathway still needs to be validated by experimental studies. 
The biological pathways of genes under regulation of the miR- 
155–5p were investigated using DIANA TOOLS-miRPath v.3 confirmed 
by DAVID. These applications are related to kyoto encyclopedia of genes 
and genomes (KEGG) Pathway and Gene Ontology (GO). The result 
showed sixteen and thirteen pathways were correlated with miR-155–5p 
(Table 3). 
Several signaling pathways related to foam cell formation were 
discovered. The role of miR-155–5p in ox-LDL uptake by targeting 
3′UTR of CD36 was shown in cholesterol metabolism pathway 
(hsa04979) and phagosome (hsa04145). The endocytosis of ox-LDL was 
also predicted to be regulated by miR-155–5p by translational repres-
sion of Vav3 from the functional annotations’ plasma membrane 
(GO:0099632: protein transport within plasma membrane) and regula-
tion of actin cytoskeleton (hsa04810). Furthermore, suggestive role of 
miR-155–5p in increasing ABCA1 expression by inhibit the expression of 
SOCS1 could be seen from the signaling pathway related with Ubiquitin- 
mediated proteolysis (hsa04120). 
The ox-LDL uptake and endocytosis are two parts of phagocytosis 
function from macrophage that determine the foam cell formation. 
Several biological processes and molecular functions from STRING 
database were matched from DIANA and DAVID analysis (Table 4). The 
biological processes GO:0010887, GO:0010885, GO:0060100GO: 
0071404, GO:0038096, hsa04666 were linked with cholesterol meta-
bolism, phagosome pathways and associate with foam cell formation 
(GO:0010745, GO:0010743). The similar pathway was found for Ubiq-
uitin mediated Proteolysis. Therefore, the regulation of ABCA1 
degradation-SOCS1 dependent by miR-155–5p was important to be 
Fig. 3. Network analysis for miR-155–5p and target genes. The above network analysis, miRNA-gene targets networks, was performed using Cytoscape 3.8.3. The 
below network analysis, protein-protein of miRNAs candidate target interaction was conducted using String. The bold line indicated strong correlation, whereas the 
thin line showed the opposite. 
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validated in wet laboratory studies. 
The integrated pathways simulation for CD36, SOCS1, and Vav3 
regulated by miR-155–5p in foam cell context was presented with Bio-
render application as seen in Fig. 4. 
2.4. Literature studies of miR-155–5p function in atherosclerosis 
The roles of miRNAs in the atherosclerosis provides new perspectives 
on disease mechanisms and have revealed potential diagnostic and 
therapeutic targets. Bioinformatic tools determined the common miRNA 
and predicted the function associate with foam cell atherosclerosis. It is 
overestimate to conclude the role of miR-155–5p in foam cell athero-
sclerosis only by bioinformatic analysis. Therefore, the review from 
available studies was performed to give brief overview about the role of 
miR-155–5p in foam cell atherosclerosis. 
A total of forty and two hundred and sixth articles was retrieved in 
the first search using Pubmed and ProQuest database. The inclusion 
criteria in this study were [1]: one key word must be involved miR-155 
or miR-155–5p [2]; the sample was macrophage cell [2], must have one 
parameter that assess the foam cell number, and [3] the cell must be 
treated with ox-LDL. The exclusion were as follows [1]: the review ar-
ticles [2], the original articles that was not relevant for key terms [3], 
the in vivo, human, and pharmacological studies. By reading the title 
and abstract, a total of eighteen articles were eligible for further review 
(Fig. 5.). Subsequently, after reading the text comprehensively, eleven 
articles were included in the review (Table 5). 
Out of the eleven selected original articles, ten papers used cell line 
RAW 264.7 or THP1, while only one study worked with macrophage 
primary culture. Furthermore, in all experiments, ox-LDL was used to 
create foam cell model with the range dose from 20 to 80 μg/ml for 
different time. Several studies measured foam cell as the outcome 
parameter, while others combined the balance between lipid uptake and 
efflux (Table 5). 
3. Discussion 
Numerous reports clearly indicates the important role of miRNAs in 
atherosclerosis. Foam cell is a key factor that not only play as the early 
marker of atherosclerosis, but also drive the inflammation process in 
atherogenesis. Our findings demonstrated that 3′UTR of CD36, Vav3, 
and SOCS1, the molecules that involved in foam cell formation, was 
targeted by miR-155–5p. BIC gene (MIR155) is encoded miR-155. This 
gene which consists of 3 exons has many starts and stop codons but lack 
Open Reading Frame (ORF). The transcription of the MIR155 produces 
pri-miR-155. Exportin-5 translocate the pri-miR-155 from the nucleus to 
cytoplasm. Dicer enzyme cleaves the terminal loop of this molecule 
resulting in RNA duplexes of ~22 nucleotides or pre-miR-155. 
Following Dicer cleavage, an Argonaute (AGO) protein binds to the 
short RNA duplexes, forming the core of a multi-subunit complex called 
the RNA-induced silencing complex (RISC). The passenger miRNA is 
released and degraded, while the other strand, the guide strand, is 
retained within the RISC. Recent data suggest that both arms of the pre- 
miRNA hairpin (-5p and -3p) can give rise to mature miRNAs [20,42]. 
However, it is overestimate to prove the role of miR-155–5p in the 
foam cell atherosclerosis only by identify the miRNAs targeting three 
genes. The reason was because CD36, Vav3, and SOCS1 could be 
expressed in many cell types, disease, and can be induced by different 
stimulus. Thus, the next strategy in this study was exploring the possible 
role of miR-155–5p in foam cell atherosclerosis by performing 
Table 3 
List of biological pathways related to miR-155–5p.   
DIANA TOOLS - miRPath v.3 DAVID 
hsa04350 TGF-beta signaling pathway GO:0007155 Cell adhesion 
hsa04010 MAPK signaling pathway GO:0045121 Membrane raft 
hsa04722 Neurotrophin signaling 
pathway 
GO:0009986 Cell surface 
hsa00601 Glycosphingolipid 
biosynthesis - lacto and 
neolacto series 
GO:0005886 Plasma membrane 
hsa04014 Ras signaling pathway GO:0005829 Cytosol 
hsa00601 Arrhythmogenic right 
ventricular cardiomyopathy 
(ARVC) 
GO:0001954 Positive regulation of 
cell-matrix adhesion 
hsa05161 Hepatitis B hsa04660 T cell receptor 
signaling pathway 
hsa04390 Hippo signaling pathway hsa04810 Regulation of actin 
cytoskeleton 
hsa04917 Prolactin signaling pathway hsa04662 B cell receptor 
signaling pathway 
hsa00510 N-Glycan biosynthesis GO:0061630 Ubiquitin protein 
ligase activity 
hsa04668 TNF signaling pathway GO:0016567 Protein 
ubiquitination 
hsa04550 Signaling pathways 




hsa04662 B cell receptor signaling 
pathway 
hsa4145 Phagosome 
hsa05212 Pancreatic cancer   
hsa04660 T cell receptor signaling 
pathway   
hsa05142 Chagas disease (American 
trypanosomiasis)    
Table 4 
Biological pathways related to the protein-protein interaction.  
Biological process (GO) KEGG Pathway 
Index Description Index Description 
GO:0010887 Negative regulation of 
cholesterol storage 
hsa04664 Fc epsilon RI 
signaling pathway 
GO 0050702 Interleukin-1 beta secretion hsa04662 B cell receptor 
signaling pathway 
GO:0010885 Regulation of cholesterol 
storage 
hsa04975 Fat digestion and 
absorption 
GO:0060100 Positive regulation of 
phagocytosis, engulfment 
hsa04666 Fc gamma R- 
mediated 
phagocytosis 
GO:0071404 Cellular response to low 




GO:0010745 Negative regulation of 
macrophage derived foam cell 
differentiation 
hsa04660 T cell receptor 
signaling pathway 
GO:0042953 Lipoprotein transport hsa04650 Natural killer cell 
mediated 
cytotoxicity 
GO:0010743 Regulation of macrophage 
derived foam cell 
differentiation 
hsa03320 PPAR signaling 
pathway 
GO:0043552 Positive regulation of 
phosphatidylinositol 3-kinase 
activity 
hsa04670 Leukocyte trans- 
endothelial 
migration 
GO:0060334 Regulation of interferon 




GO:0038096 Fc-gamma receptor signaling 
pathway involved in 
phagocytosis 
hsa04120 Ubiquitin mediated 
proteolysis 
GO:1904645 Response to amyloid beta hsa04062 Chemokine 
signaling pathway 
GO:0050663 Cytokine secretion hsa04510 Focal adhesion 
GO:0038095 Fc-epsilon receptor signaling 
pathway 
hsa04152 AMPK signaling 
pathway 
GO:0030032 Lamellipodium assembly hsa04611 Platelet activation 
GO:0048010 Vascular endothelium growth 
factor receptor signaling 
pathway 
hsa04024 cAMP signaling 
pathway 
GO:0050853 B cell receptor signaling 
pathway 
hsa04810 Regulation of actin 
cytoskeleton 
GO:0031295 T cell co-stimulation    
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functional enrichment analysis. Interestingly, several pathways such as 
cholesterol metabolism (hsa04979), phagosome (hsa4145), positive 
regulation of phagocytosis (GO:0060100), Fc gamma receptor signaling 
pathway involved in phagocytosis (GO:0038096), regulation of actin 
cytoskeleton (hsa04810), regulation of macrophage derived foam cell 
differentiation (GO:0010743), PPAR signaling pathway (hsa03320), 
ubiquitin mediated proteolysis (hsa04120) were related to foam cell 
atherosclerosis. 
Recent studies showed the miR-155–5p was high not only in in vitro 
atherosclerosis models, but also in both circulating and atherosclerotic 
lesions in both mice and humans. According to the researches conducted 
by Du et al., in 2014 and by Nazari-Jahantigh et al., in 2012, C57BL/6, 
ApoE -/-, LDR -/- mice aged 3–7 months administered with High Fat Diet 
(HFD) or partially ligated in their carotid arteries, then stained with Oil 
Red O (ORO) and Monocyte + Macrophage antibody (MOMA), showed 
the increase number of foam cell compared to control [43](38). Signif-
icant differences in circulating miR-155–5p and atherosclerotic lesion in 
individuals with coronary artery disease were higher compared with 
healthy individuals [44]. 
Interestingly, the role of miR-155–5p in the foam cell formation re-
mains controversial. Several works showed an anti-atherogenic profile, 
while others demonstrated pro-atherogenic properties. The papers that 
concluded miR-155–5p as pro-atherogenic did not specifically measure 
the outcome of atherosclerosis. Most of the publications used the in-
flammatory cytokine production to conclude the effect of this miRNA, 
but not specifically measure the number of foam cell, the lipid uptake 
and the cholesterol efflux. Moreover, the pro-atherogenic studies used 
macrophage cells that treated with LPS, which not naturally express the 
preference type of macrophage to produce foam cell. M2 macrophage 
phenotype with high endocytic capacity is the origin of foam cell since 
the foam cell formation is a physiological process to phagocytose ox- 
LDL. Nevertheless, in the chronic state, the foam cell function change 
into pro-inflammatory due to cholesterol metabolism dysregulation. The 
uptake of ox-LDL predominantly occurs through CD36 which expressed 
higher in M2 macrophages compared to M1 [45]. Therefore, the ex-
amination of new perspectives for the development of the foam model 
was considered. We suggest to use M-CSF, IL-4 as inducer for macro-
phages differentiation than LPS, which hopefully could answer the 
contradiction role of miR-155–5p in atherosclerosis [46,47]. 
Another possibility of this conflicting result was answered by Bruen 
analysis which concluded that the function of miR-155–5p depend on 
the phase of atherosclerosis. The miR-155–5p suppress atherosclerosis in 
the early phase, while it shows the opposite effect in the advanced phase 
[48]. Several studies using ApoE− /− mice as a model for advance phase 
of atherosclerosis demonstrated that the injection of antagomir-155 
attenuated atherosclerosis development and progression in ApoE− /−
mice [35]. In contrast, LDLr− /− mice transplanted with 
miR-155-deficient bone marrow as model for early atherosclerosis had 
increased atherosclerotic plaques, elevated levels of pro-inflammatory 
monocytes, and decreased IL-10 production from peritoneal macro-
phages [49]. 
Overall, our findings give predictions which need to be validated by 
laboratory experiments to conclude the role of miR-155–5p in foam cell 
atherosclerosis inhibition through CD36, Vav3, and SOCS1. Another 
limitation of this study is our review did not specify the method to show 
that miR-155–5p regulate directly the target genes. Many papers used 
miR-155 mimic or inhibitor to study the role of this miRNA in foam cell 
formation. Recent publications by Ye et al. 2016, Chang et al. 2016, 
Zhang et al., 2020 demonstrated that SOCS1 was the direct target of 
miR-155–5p by performing a luciferase reporter assay using HEK293 
cells. The cells were co-transfected with the wild-type (WT) or mutated 
(Mut) SOCS1 luciferase reporter vector, together with miR-155 mimic 
and the control for 24 and 48 h. The result showed that luciferase ac-
tivity was significantly inhibited in cells transfected with WT SOCS1 and 
miR-155 mimic, but not in cells transfected with mutation SOCS1 and 
miR-155 mimic [33,50,51]. Therefore, our results provide justification 
Fig. 4. The proposed role of miR-155–5p in foam cell atherosclerosis inhibition through CD36, VAV3, and SOCS1. The ox-LDL uptake is mediated by CD36. The 
binding of ox-LDL with CD36 activates the Lyn which subsequently activates the Vav3. Vav3 increases the expression of Rac/Rho kinase, which is an important 
molecule in the up-regulation of dynamin that build the endocytic vesicle structure. The vesicles fuse with the membrane cell and endocytose the ox-LDL. Inside the 
cell, the content of ox-LDL is hydrolyzed and the free cholesterols are released into the cytoplasm. High lipid induces the inflammation process that stimulates the 
SOCS1. This transcription factor acts as the E3 ligase that leads the ABCA1 to proteasome for degradation. 
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for further evaluation about the role of miR-155–5p in foam cell 
atherosclerosis by doing luciferase assay to get transcriptional activity 
profile of miRNA with 3′UTR of gene targets. 
Available studies did not clearly mention the type of miR-155 use, 
either -5p or -3p. miRdB database informs that the previous name of 
miR-155–5p is miR-155. Moreover, miR-155–5p is the predominant 
functional miR-155 and also expressed 20-fold to 200-higher than miR- 
155–3p [52]. Further studies need to specify which type of miR-155 is 
used. Furthermore, the comparative studies about the role of 
miR-155–5p and -3p in foam cell atherosclerosis should be performed. 
4. Conclusion 
Foam cell atherosclerosis is not only determined the beginning of 
atherosclerosis, but also plays a key role in its progression. The miR- 
155–5p is upregulated in macrophages treated with ox-LDL. Our 
findings revealed the predictive role of miR-155–5p to inhibit foam cell 
atherosclerosis through CD36, Vav3, and SOCS1 pathway. However, 
given some conflicting results, further studies are required to investigate 
the stage-specific effects of miR-155–5p inhibition during atheroscle-
rosis progression using M2 phenotype macrophage. In addition, the 
direct binding of miR-155–5p to the gene targets should be studied. 
Moreover, the miR-155–5p function in several other key aspects of foam 
cell formation such as autophagy process, the preference needs of 
metabolic supply is needed to be elucidated in further investigation. 
5. Material and method 
5.1. Identification of microRNA targeting CD36, VAV3, and SOCS1 
The identification of miRNAs targeting 3′UTR of CD36, VAV3, and 
SOCS1 were performed using TargetScan 7.2 (http://www.targetscan. 
Fig. 5. PRISMA flowchart for systematic literature review to evaluate the role of miR-155–5p in foam cell atherosclerosis.  
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org/vert_72/) and MicroRNA Target Prediction Database (miRdB) (htt 
p://www.mirdb.org/) for cross validation. The CD36, Vav3, and 
SOCS1 gene reference sequences were retrieved from the https://www. 
ensembl.org/with reference numbers ENSG00000135218, 
ENSG00000134215, and ENSG00000185338, respectively. The valida-
tion prediction of miRNAs targeting CD36, Vav3 and SOCS1 genes by 
TargetScan 7.2 was showed in context ++ score, conserved branch 
lengths, and PCT [21,53]. The prediction of miRNAs using miRdB was 
demonstrated with the cut off value of 80 [22,23]. 
5.2. Profile of common miRNA targeting CD36, VAV3, and SOCS1 
The similar miRNA targeting CD36, SOCS1, and Vav3 based on 
miRdB and TargetScan 7.2 was selected with Venn diagram analysis. 
This miRNA was predicted to be a strong candidate for studying its role 
in foam cell atherosclerosis. The profile of common miRNA and the 
interaction with the genes was evaluated using miRdB and TargetScan 
7.2 database. The data includes the mature miRNA sequences, the 
interaction position between miRNA’s seed sequences and 3′UTR of 
target genes. The conserved physiological binding sites of 3′ UTR in 
three genes across among different species was also demonstrated using 
TargetScan 7.2. 
5.3. Functional enrichment analysis of miRNA targets 
The Cytoscape 3.8.3 was used to construct the miRNAs-mRNAs 
network followed by determination pathway enrichment analysis with 
DIANA TOOLS-miRPath v.3 and Database for Annotation, Visualization 
and Integrated Discovery (DAVID) v6.8 [25,54,55]. These tools provide 
information on the functional notations of miRNA that are experimen-
tally supported using Gene Ontology (GO) or GO Slim terms, combined 
with statistically-enriched pathways, such as Kyoto Encyclopedia of 
Genes and Genomes (KEGG) molecular pathways, and was based on 
target genes that query miRNAs targets. Moreover, to ensure the validity 
Table 5 
Summary of recent papers studying the role of miR-155–5p in foam cell atherosclerosis.  
Type Title Reference Sample and Treatment Results 
antiatherogenic miR-155 acts as an anti-inflammatory factor in 
atherosclerosis-associated foam cell formation by 
repressing calcium-regulated heat stable protein 1 
[31] the monocyte THP-1 cell line. After stimulated with 100 
nM PMA, the monocyte differentiated to macrophage. 
The macrophage were transfected with 100 nM miR-155 
mimic or miR-155 inhibitor for 0, 6, 12, 24, or 48 h, 
followed by treatment with 50 μg/ml oxLDL for 24 h. 
↓ TNFα 
↓ foam cell 
MiR-155 inhibits transformation of macrophages into 
foam cells via regulating CEH expression 
[32] Human THP-1 cells were differentiated into macrophages 
by adding 100 PMA for 72 h. The macrophages were 
transformed into foam cells by co-incubating in 50 μg/ml 
ox-LDL, 0.3% bovine serum albumin (BSA) in serum-free 
RPMI 1640 medium for 48 h foam cells were transfected 
with miR-155 mimics (40 nM) for 24 h at 37 ◦C, then grown 
for 24 h in 10% fetal bovine serum and without antibiotics. 
↑CEH 
↑cholesterol efflux 
↓contents of CE, FC, TC 





miR-155 Regulated Inflammation Response by the 
SOCS1-STAT3-PDCD4 Axis in Atherogenesis. 
[33] macrophage Raw264.7 cell line 
were exposed with 20 μg/ml ox-LDL for 24 h and 





↓ foam cell 
MicroRNA-155 silencing enhances inflammatory 
response and lipid uptake in oxidized low-density 
lipoprotein-stimulated human THP-1 macrophages. 
[34] THP-1 cell line was differentiated into macrophage by 
adding PMA 100 nm for 24 h. 
Silencing of endogenous miR-155 in THP-1 cells using 
locked nucleic acid-modified antisense oligonucleotides. 
The cells were incubated for 24 h posttransfection and then 
exposed to oxLDL (50 kg/ml) for another 24 h 
↑oxLDL-induced lipid 
uptake, 
↑LOX-1, CD36, and 
CD68 
↑ IL-6, -8, and TNFα 
miR-155 inhibits oxidized low-density lipoprotein- 
induced apoptosis of RAW264.7 
[35] RAW 264.7 cells were transfected with synthetic miR-155 
mimics (M, 80 nM) 
↑FADD 
↑Apoptosis 
Regulation of microRNA-155 in atherosclerotic 
inflammatory responses by targeting MAP3K10. 
[36] The human monocytic cell line THP-1 were cultured with 




miR-155 inhibits oxidized low-density lipoprotein- 
induced apoptosis in different cell models by targeting 
the p85α/AKT pathway. 
[37] Raw264.7 cells were transfected with miR-155 mimics or 
inhibitor for 24 h. Following transfection, the cells were 
stimulated with OxLDL 80 μg/ml for 12 h 
Prevent cytotoxicity 
↓apoptosis 
Proatherogenic MicroRNA-155 promotes atherosclerosis by repressing 
Bcl6 in macrophages. 
[38] BM cells were harvested from the femurs of Mir155+/ 
+/Apoe− /− and Mir155− /− /Apoe− /− mice, cultured for 
7 days to allow differentiation into primary macrophages 
treated with siRNA or siRNA against Socs1, Sfpi1, and Bcl6 
on Day 4 
stimulated with moxLDL and IFNγ on Day 7. 
Loss of Mir155 reduced 
the expression of CCL2 
MicroRNA-155 Promotes Atherosclerosis Inflammation 
via Targeting SOCS1. 
[39] THP-1 cells were exposed to PMA 100 nm. Then the cells 
were stimulation with oxLDL 50 μg/ml for 24 h. Thus the 







microRNA-155 promotes the ox-LDL-induced activation 
of NLRP3 inflammasomes via the ERK1/2 pathway in 
THP-1 macrophages and aggravates atherosclerosis in 
ApoE− /− mice. 
[40] THP-1 monocytes were stimulated with. PMA 100 ng/ml to 
induce the differentiation of THP-1 monocytes into 
macrophages for 48 h. The differentiated macrophages 
were then treated with 50 μg/ml ox-LDL for 24 h. 
The cells transfected with miR-155 mimic and miR-155 







Elevated microRNA-155 promotes foam cell formation by 
targeting HBP1 in atherogenesis. 
[41] RAW264.7 were transfected with miR-155 mimic or 
inhibitor for 48 h than stimulated with oxLDL for 24 h 
↑ lipid uptake 
↑ ROS 
↓ HBP1  
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of the results, STRING 11.0 (https://string-db.org/) database were also 
performed to provide a critical assessment and integration of protein–-
protein interactions, including direct (physical) as well as indirect 
(functional) associations. All data available in STRING were provided 
with a probabilistic confidence score. Targets with a confidence score 
greater than 0.4 were selected to construct the network (26). The pro-
posed mechanism of miR-155–5p role in foam cell inhibition through 
CD36, Vav3, and SOCS1 pathway was demonstrated using Biorender 
application (16). 
5.4. Review of miR-155–5p function from available studies 
The articles from Pubmed and Proquest database, written in English 
language, and published for the past 10 years (2010–2020) was carried 
out. A retrieval strategy was created with the input from an expert 
librarian, and the search strategy was performed encompassing terms 
such as (miR-155 OR miR-155–5p) AND ((foam cell) OR (macrophage)) 
AND atherosclerosis. The expression level of miR-155–5p was high in 
monocyte-macrophage cells whereas miR-155–3p expression was very 
low. Furthermore, miRdB showed that miR-155–5p previous name was 
miR-155. Therefore, we used miR-155 for inclusion criteria to per-
formed the review. 
The data excluded following criteria [1]: Article review, editorial, 
comment, or interview [2]; in vivo or human studies [3]; Studies that 
does not include the macrophages cell [4]; Pharmacological studies; and 
duplication. 
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